LAVAL, Quebec, Oct. 17, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. VRX VRX today announced that it plans to release third quarter 2016 financial results on Tuesday, November 8, 2016, prior to the conference call and live webcast at 8:00 a.m. ET, when the Company will discuss the results.
|
Conference Call Details | |
|
Date |
Tuesday, November 8, 2016 |
|
Time |
8:00 a.m. ET |
|
Webcast |
|
|
Participant Event Dial-in |
(877) 876-8393 (North America) |
|
(973) 200-3961 (International) | |
|
Participant Passcode |
49468113 |
|
Replay Dial-in |
(855) 859-2056 (North America) |
|
(404) 537-3406 (International) | |
|
Replay Passcode |
49468113 (replay available until November 16, 2016) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Contact Information:
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-announces-third-quarter-financial-results-date-and-conference-call-details-300345912.html
SOURCE Valeant Pharmaceuticals International, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
